Task-based mirror therapy for shoulder-hand syndrome after stroke

Effects of Task-based Mirror Therapy on Edema, Pain and Upper Limb Motor Function for Post-stroke Shoulder-hand Syndrome

NA · Riphah International University · NCT07428811

This trial will try mirror therapy tasks to reduce swelling and pain and improve arm and hand movement in people aged 45–75 with shoulder-hand syndrome after a stroke.

Quick facts

PhaseNA
Study typeInterventional
Enrollment34 (estimated)
Ages45 Years to 75 Years
SexAll
SponsorRiphah International University (other)
Locations2 sites (Lahore, Punjab Province and 1 other locations)
Trial IDNCT07428811 on ClinicalTrials.gov

What this trial studies

This randomized interventional trial will enroll 34 participants at two clinics in Lahore and randomly assign them to a task-based mirror therapy group or a control group receiving conventional exercises. Treatments last 30 minutes per day, five days a week, for four weeks, with each movement repeated in sets (20 repetitions per set, three sets) and brief rest intervals. Primary outcomes include pain intensity (Numeric Pain Rating Scale), edema (figure-of-eight method), and upper limb motor function, measured before and after the intervention. The protocol targets subacute stroke patients and uses a convenience sampling method with online randomization to allocate participants.

Who should consider this trial

Good fit: Ideal candidates are people aged 45–75 with subacute stroke (less than 6 months), able to sit, with sufficient cognition (MoCA ≥ 24), moderate spasticity (Modified Ashworth Scale ≤ 2), no severe contractures, and no peripheral nerve or major musculoskeletal disorders.

Not a fit: Patients with severe apraxia, unilateral neglect, global or receptive aphasia, severe contractures, significant comorbidities that prevent participation, or those outside the age or stroke-timing criteria are unlikely to benefit from this protocol.

Why it matters

Potential benefit: If successful, the approach could reduce pain and swelling and improve arm and hand function for people recovering from stroke.

How similar studies have performed: Previous mirror therapy studies have shown mixed but promising results for post-stroke motor recovery and pain reduction, while task-based mirror therapy for shoulder-hand syndrome is less extensively studied.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria: Age 45 to 75 years.

* Both male and female patients are included in the study.
* Subacute stroke patients having stroke less than 6 months are included in this study.
* Stable participants having a stroke severity score \> 6 on National Institute of Health Stroke Scale (NIHSS).
* Modified Ashworth scale score ≤ 2 of the affected upper extremity.
* Montreal Cognitive Assessment (MoCA) score ≥ 24.
* Patients who can sit with or without support.
* No contractures of the affected shoulder, elbow, wrist and fingers.
* Participants who have no history of peripheral nerve injury or musculoskeletal disease

Exclusion Criteria:

* • Participants who have medical problems or co-morbidities that interdict their participation in the study.

  * Patients with severe apraxia, somatosensory problems.
  * Unilateral neglect
  * Severe contractures of the affected shoulder, elbow, wrist and finger.
  * Participants who show the symptoms of global or receptive aphasia.

Where this trial is running

Lahore, Punjab Province and 1 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Stroke, Edema, pain, shoulder hand syndrome, Task based mirror therapy, upper limb motor function

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.